Drugs

Regulators consider waiving prescription for diabetes

Some of the most widely used prescription drugs, including those to treat cholesterol and high blood pressure, could be available over the counter under a new proposal being weighed by government regulators.

Diabetes drug breakthrough hope for Indigenous

A new drug for diabetics is expected to improve the treatment of high levels of chronic kidney disease in Indigenous communities.

FDA may fine Merck over Diabetes drug

U.S. drug regulators may fine Merck for failing to test whether its diabetes drugs Januvia and Janumet can raise the risk of an inflamed pancreas, according to a warning letter posted online on Tuesday.

Diabetes, memory loss warnings added to statins

U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to indicate that they may raise levels of blood sugar and could cause memory loss.

Diabetes patients praising new ‘wonder drug’

Can a shot make you skinny? A new injection is changing the lives of diabetes patients — by changing their waistlines.

New Diabetes Drug Cuts Glycemic Risk

A novel agent that activates a free fatty acid receptor successfully increased insulin secretion without raising the risk of hypoglycemia in patients with type 2 diabetes, a randomized study found.

Experimental Drug Shows Promise Against Type 2 Diabetes

An experimental drug improves patients’ blood sugar control without increasing the risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, according to the results of a phase 2 clinical trial.

Phase 2 Data of GPR40 Agonist Demonstrated Improved Glycemic Control

Phase 2 clinical data of an investigational type 2 diabetes therapy, TAK-875 of Takeda Pharmaceutical Company Limited (“Takeda”), were published online first in The Lancet.

Diabetes drug helping patients lose weight

Victoza seems to work by turning off appetite. Another diabetes drug — Byetta — has similar results. Could someone who’s not diabetic use the shot to drop pounds?

Sirona reports positive preclinical results of diabetes compound

Sirona Biochem, a biotechnology company, has announced that SBM-TFC-039, significantly and rapidly reduced the blood glucose level in obese diabetic rats.

Lumena moves on to clinical trials

In 80 percent of diabetic patients treated with this novel drug, blood glucose levels normalized within days – a change that’s not attributed to weight loss.

Oral Drug Treatment of Diabetes: A Clinical Practice Guideline

The American College of Physicians issued a Clinical Practice Guideline for diabetic patients who need to add a drug treatment to control blood sugar levels.

“Smart Pills” Send Stats to Smartphones

Pharmaceutical companies are developing a pill containing a biodegradable chip along with the medication to send information on patient’s vital statistics to a smartphone.

FDA approves DES for treatment of CAD in diabetic patients

The Resolute clinical trial program enrolled more than 5,000 patients worldwide, a third of whom had diabetes.

Metformin reduces cancer mortality

A recent analysis has found that cancer patients with diabetes who were on Metformin monotherapy have a significantly reduced overall mortality compared with cancer patients without diabetes.

J&J’s Risperdal® Wasn’t Factor in Man’s Diabetes

Johnson & Johnson’s anti-psychotic drug Risperdal wasn’t a substantial factor in causing a Nebraska man’s diabetes.

CHMP Recommends BYETTA® for Use With Basal Insulin

The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA® as an add-on therapy to basal insulin.

Harvard Experts answer: Do I need to start drug therapy for diabetes?

The American Diabetes Association’s established that patients just diagnosed with type 2 diabetes should start taking metformin right away

US Drug Watchdog Encourages Actos® Users to Take Action

The US Drug Watchdog says that they need the help of family members, and loved ones of diabetics who now have bladder cancer to ask the diabetic if they were using the diabetes drug called Actos, prior to being diagnosed with bladders cancer.

Novo Nordisk’s New Drug Latest Results

Novo’s Victoza is the leading drug in the GLP-1 analogue class, a relatively new class of injectable drugs which adds to the existing choices of oral treatments and short and long-acting insulin products.